Publisher(favicon_url='https://s3.massive.com/public/assets/news/favicons/themotleyfool.ico', homepage_url='https://www.fool.com/', logo_url='https://s3.massive.com/public/assets/news/logos/themotleyfool.svg', name='The Motley Fool')•2025-08-21
BOS Reports 36 Percent Revenue JumpRFL — Rafael Holdings Inc
NYSE · Pharmaceuticals · Pharmaceuticals
$1.28-16.34%Market cap66.07M
- Latest Close
- $1.28
- 30-Day Move
- -16.3%
- Market Cap
- $66M
- Shares Outstanding
- 51,760,000
- P/B Ratio
- 0.92
- ROE
- -32.3%
NYSE:RFLPharmaceuticals / PharmaceuticalsDelayed public snapshot
Rafael Holdings Inc
A read-only Alphactor snapshot forRafael Holdings Inc. It uses the same research structure as the app, but with delayed data and shallow depth so search visitors can evaluate the stock before signing up.
Snapshot as of2026-04-21
Topline snapshot
Latest Close
$1.28
30-Day Move
-16.3%
Market Cap
$66M
Shares Outstanding
51,760,000
P/B Ratio
0.92
ROE
-32.3%
Not investment advice. Signals and scores shown here are model outputs derived from historical data, not recommendations. Past performance does not guarantee future results. Do your own research before trading. Full disclaimer
Chart snapshot
$1.28
-16.3%last 90 delayed daily bars
Market cap$66M
90D High
$1.60
90D Low
$1.12
Avg Volume
97,116
What stands out
Gross margin is running at 89.7%, which gives a quick read on operating quality before you open the full model.
Net margin is -3044.7%, useful for comparing RFL against peers in Pharmaceuticals.
RFL is down 16.3% over the last 30 trading days shown on this page.
Latest operating income is $-7M, which helps anchor the headline ratios with an actual earnings figure.
Research snapshot
Rule of 40
-1124.4%
Dark Pool Short %
9.8%
Fundamentals snapshot
Latest Close
$1.28
30-Day Move
-16.3%
Market Cap
$66M
Shares Outstanding
51,760,000
P/B Ratio
0.92
ROE
-32.3%
ROA
-26.8%
Gross Margin
89.7%
Operating Margin
-3442.4%
Net Margin
-3044.7%
Debt / Equity
0.01
Current Ratio
4.89
Latest Revenue
$211,000
Financial statement snapshot
Revenue
$211,000
Gross Profit
$199,000
Operating Income
$-7M
Net Income
$-6M
Gross Margin
8970.0%
Net Margin
-304470.0%
Current Ratio
4.89
Debt / Equity
0.01
Quality snapshot
Altman Z
-0.94
Distress
Piotroski
0
Weak (0-3)
Cash Conversion
--
Rule of 40
-1124.4%
Concerning
Annual financial history
Annual performance mix
| Period | Revenue | Operating Income | Net Income | Free Cash Flow |
|---|---|---|---|---|
| 2022-12-31 | $410,000 | $-60M | $-125M | $-16M |
| 2023-12-31 | $279,000 | $-15M | $-2M | $-26M |
| 2024-12-31 | $637,000 | $-103M | $-34M | $-11M |
| 2025-12-31 | -- | -- | -- | $-8M |
After signup
The app opens the full statement deep dive
Extend the history well beyond this public snapshot to inspect longer cycles and regime changes.
Move from summary lines into detailed balance-sheet and cash-flow rows for working capital, debt, and capex analysis.
Cross-link statement changes with alerts, watchlists, and saved research workflows after signup.
News snapshot
Publisher(favicon_url='https://s3.massive.com/public/assets/news/favicons/benzinga.ico', homepage_url='https://www.benzinga.com/', logo_url='https://s3.massive.com/public/assets/news/logos/benzinga.svg', name='Benzinga')•2025-04-24
Rafael Holdings Strengthens its Focus on the Development of Trappsol® Cyclo™ and Announces Chief Executive Officer Bill Conkling Will Be Stepping Down from His RolePublisher(favicon_url='https://s3.massive.com/public/assets/news/favicons/benzinga.ico', homepage_url='https://www.benzinga.com/', logo_url='https://s3.massive.com/public/assets/news/logos/benzinga.svg', name='Benzinga')•2025-03-26
Rafael Holdings Completes Merger with Cyclo Therapeutics Following Shareholder ApprovalsPublisher(favicon_url='https://s3.massive.com/public/assets/news/favicons/benzinga.ico', homepage_url='https://www.benzinga.com/', logo_url='https://s3.massive.com/public/assets/news/logos/benzinga.svg', name='Benzinga')•2025-03-13
Rafael Holdings Reports Second Quarter Fiscal 2025 Financial ResultsPublisher(favicon_url='https://s3.massive.com/public/assets/news/favicons/globenewswire.ico', homepage_url='https://www.globenewswire.com', logo_url='https://s3.massive.com/public/assets/news/logos/globenewswire.svg', name='GlobeNewswire Inc.')•2025-03-13
Rafael Holdings Reports Second Quarter Fiscal 2025 Financial ResultsAfter signup
The full sentiment workspace adds context
Go past the public headlines into fuller article history, source cross-checks, and deeper narrative tracking.
Tie news into alerts, watchlists, and conviction changes instead of browsing one static batch of stories.
Insider activity snapshot
Buy Value
$17M
Sell Value
$0
Buys
3
Sells
0
Buy Value
$17M
Sell Value
$0
Buy/Sell Ratio
3.00x
After signup
The full app goes deeper on insider behavior
Inspect longer insider history, recurring buyers and sellers, and the broader transaction context beyond this snapshot.
Continue into deeper institutional and alternative-data views once you sign up.
Recent insider transactions
| Date | Name | Type | Shares | Price |
|---|---|---|---|---|
| 2026-03-21 | Polinsky David | F | 2,318 | $1.27 |
| 2026-03-13 | JONAS HOWARD S | F | 9,826 | $1.50 |
| 2026-01-28 | Sieger Markus | A | 29,528 | $1.27 |
| 2026-01-28 | STEIN MARK N | A | 39,370 | $1.27 |
| 2026-01-28 | GRAYSON ALAN | A | 6,562 | $1.27 |
| 2026-01-28 | WEISS MICHAEL J | A | 39,370 | $1.27 |
| 2026-01-13 | Polinsky David | A | 50,000 | $1.25 |
| 2026-01-13 | Polinsky David | F | 4,865 | $1.25 |
ETF holders snapshot
| ETF | Shares | Weight | As Of |
|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 747,724 | 0.01% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 518,191 | 0.01% | 2025-12-31 |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 208,228 | 0.00% | 2026-02-28 |
| DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Micro Cap Portfolio | 92,711 | 0.00% | 2026-01-31 |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 74,962 | 0.00% | 2026-02-28 |
| iShares Trust-iShares Micro-Cap ETF | 55,987 | 0.00% | 2026-01-31 |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 58,483 | 0.00% | 2026-02-28 |
| Dimensional ETF Trust-Dimensional U.S. Small Cap ETF | 27,736 | 0.00% | 2026-01-31 |
After signup
The deeper ownership view shows who is leaning in
Open richer institutional and holder diffs to see position changes across filings instead of one static snapshot.
Use those ownership shifts alongside conviction and alerts in the full app workflow.
Institutional holders snapshot
FMR LLC (Fidelity)
Filed 2026-02-17
--
--
Vanguard Group
Filed 2025-08-11
$2M
+25.8%
Geode Capital Management
Filed 2025-08-08
$780,627
+72.9%
BlackRock
Filed 2024-05-10
$328,415
--
Northern Trust
Filed 2025-11-14
$114,887
+39.2%
Dark-pool activity snapshot
For informational and educational purposes only. Not financial advice. Learn more
Related reading
Research and strategy guides from the alphactor blog.
Accruals Quality: How to Spot Earnings That Aren't Real
Accruals measure the gap between reported earnings and actual cash. Widening accruals is one of the most reliable red flags in financial analysis — Sloan's…
Altman Z-Score: A Bankruptcy Predictor That Still Works
Edward Altman's 1968 discriminant model predicts bankruptcy within two years about 72% of the time at its distress threshold.
Balance Sheet Deep Dive
Balance sheet changes lead income statements by 2-6 quarters. Net debt, receivables days, and goodwill are the lines that move stocks first.